Trial intelligence / Profile preview

Midazolam pharmacokinetics in elderly ICU patients

NL-OMON22131Not yet recruiting

Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of midazolam, sponsored by None. Primary endpoint: Midazolam pharmacokinetic profile. Planned start Mar 2019; status: not yet recruiting.

02

Drugs

midazolam

Beyond the preview

Go deeper on NL-OMON22131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call